PTC Therapeutics, Inc.
PTCTNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $5.58B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $58.80$90.87
- Volume (live)
- -
- Avg. volume (3M)
- 1.20M
PTC Therapeutics (PTCT) Stock Price & Financial Analysis
PTC Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $59.98 - $61.31 |
|---|---|
| 52-Week High | $90.87 |
| 52-Week Low | $58.80 |
| Open | $61.31 |
| Volume (last close) | 674.32K |
| Average Volume (3M) | 1.20M |
| Revenue (TTM) | 1.01B |
|---|---|
| Net Income (TTM) | -38.38M |
| Free Cash Flow (TTM) | -332.56M |
| EPS (TTM) | −$0.45 |
| Profit Margin | -3.80% |
| Operating Margin | 11.52% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 5.58B |
|---|---|
| Shares Outstanding | 92.02M |
| Price to Sales (P/S) | 5.53 |
| Price to Book (P/B) | -33.72 |
| EV/EBITDA | 31.90 |
| 50-Day MA | $67.02 |
|---|---|
| 200-Day MA | $71.27 |
| 1-Year Change | −5.63% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
PTC Therapeutics at a Glance
As of the Oct 23, 2026 close, PTC Therapeutics (PTCT) has a market capitalization of $5.58B. The stock trades at 5.5× sales. Over the trailing twelve months it lost $38.38M on revenue of $1.01B and burned $332.56M of free cash flow. Revenue fell 42.8% year over year.
As of its latest reported balance sheet, it holds $1.05B in cash and securities against $590.97M of debt, a net cash position of $458.92M.
PTC Therapeutics does not currently pay a dividend.
The share price is down 5.6% over the past year. At $60.59 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $58.80 to $90.87, below its 200-day moving average of $71.27.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $95.73, 58.0% above the Oct 23, 2026 close.
Frequently Asked Questions About PTC Therapeutics
What is the current stock price for PTCT?
As of the Oct 23, 2026 close, PTCT stock trades at $60.59. The 52-week range is $58.80–$90.87, with a day range of $59.98–$61.31.
What is the P/E ratio for PTCT?
The P/E ratio (Price-to-Earnings) for PTCT is shown in the Key Statistics section. This valuation metric helps compare PTC Therapeutics, Inc. to industry peers.
Does PTCT pay dividends?
PTC Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PTCT?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for PTCT is Buy. The average 12-month price target is $95.73, a 58.0% upside from the Oct 23, 2026 close of $60.59.
What is the market cap of PTCT?
As of the Oct 23, 2026 close, PTC Therapeutics's market capitalization is $5.58B, classifying it as a mid-cap company. PTC Therapeutics operates in the Healthcare sector within the Biotechnology industry.